HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 285/6/G1181    most recent 00047.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Park, K.-S. Articles by Choi, K.-Y. Search for Related Content PubMed PubMed Citation Articles by Park, K.-S. Articles by Choi, K.-Y.

HORMONES AND SIGNALING

The ERK pathway involves positive and negative regulations of HT-29 colorectal cancer cell growth by extracellular zinc

¹Department of Biotechnology, College of Engineering, and ²Protein Network Research Center, Yonsei University, Seoul 120-752; ³Laboratory of Molecular Oncology, Korea Institute of Radiological and Medical Sciences, Seoul 136-706; and ⁴Department of Oral Biology, College of Dentistry, Yonsei University, Seoul 120-752, South Korea

Submitted 28 January 2003 ; accepted in final form 17 June 2003

Dietary zinc is an important trace element in the body and is related to both cell proliferation and growth arrest. A recent study found that extracellular zinc-sensing receptors trigger intracellular signal transduction in HT-29 human colorectal cancer cells. However, the signaling mechanism causing this growth regulation by extracellular zinc is not clearly understood. At 10- and 100-µM levels of ZnCl₂ treatment, HT-29 cell growth and proliferation increased and decreased, respectively, in a minimally serum-starved medium (MSSM). A lack of significant increase in intracellular zinc levels after zinc treatment suggested that this differential growth regulation of HT-29 cells by extracellular zinc is acquired by receptor-mediated signal transduction. Moreover, this zinc-induced growth regulation was differentially affected by PD-98059, suggesting the involvement of the ERK pathway. Transient ERK activation and subsequent cyclin D1 induction were observed on adding 10 µM ZnCl₂ in MSSM in the presence of cell proliferation. On the other hand, prolonged ERK activity was observed with a subsequent increase of cyclin D1 and p21^Cip/WAF1 on adding 100 µM ZnCl₂ in MSSM, and this was associated with nonproliferation. Moreover, this ERK activation and cyclin D1 and p21^Cip/WAF1 induction were abolished by PD-98059 pretreatment. The differential regulations of cell growth, ERK activities, and cyclin D1 and p21^Cip/WAF1 inductions were also observed in serum-enriched medium containing higher zinc concentrations. Therefore, differential cell cycle regulator induction occurs by a common ERK pathway in the differential growth regulation of HT-29 cells by extracellular zinc.

signal transduction; extracellular signal-regulated kinase; p21^Cip/WAF1

This article has been cited by other articles:

				J.-H. Lee, J.-S. Lee, S.-E. Kim, B.-S. Moon, Y.-C. Kim, S.-K. Lee, S.-K. Lee, and K.-Y. Choi Tautomycetin inhibits growth of colorectal cancer cells through p21cip/WAF1 induction via the extracellular signal-regulated kinase pathway Mol. Cancer Ther., December 1, 2006; 5(12): 3222 - 3231. [Abstract] [Full Text] [PDF]